Smart532 Laser Photocoagulator

532 nm Photocoagulation Laser with SmartPluse Technology

Smart 532™ is the newest photocoagulator by Lumenis,
enhanced with the advanced SmartPulse™ technology.

Smart532 - 532nm green laser Photocoagulation with SmartPulse Technology
  • Continuous wave and SmartPulse™ sub-threshold technology
  • Superior laser stability due to advanced laser cavity technology
  • 100% Lumenis Technology
  • Exclusive and intuitive user interface
  • Compact and lightweight
  • Dual port designed to best fit the clinic
  • 25 programmable user pre-sets
  • SureSpot™ optics technology ensures sharply defined power on the retina with safe and low density power on the cornea
  • Voice confirmation mode enables the physician to keep eyes on the patient while changing settings during treatment

What is SmartPulse™ Technology?

SmartPulse™ is a tissue-spearing solution for the treatment of retinal diseases, that allows sub-threshold retinal treatment.

Lumenis SmartPulse™ is integrated in the Smart 532™ (532nm green laser) system, to offer maximal efficacy with minimal collateral damage.

SmartPulse™ Mode

Smart pulse mode for 532 laser

Celebrating 50 years of innovation with the launch of the new retinal care photocoagulator

1970: Lumenis (previously Coherent) introduced the first argon laser photocoagulator in ophthalmology.

1970: Lumenis (previously Coherent) introduced the first argon laser photocoagulator in ophthalmology.

2016: Lumenis proudly launches the new retinal care portfolio, starring Smart 532™, the new green (532nm) laser photocoagulator with SmartPulse™.

2016: Lumenis proudly launches the new retinal care portfolio, starring Smart 532™, the new green photocoagulator with SmartPulse™.

Risks and warnings: Smart532 is contraindicated when corneal opacities, cataract formation, and vitreous hemorrhage interfere with the physician’s view of the retina. Inadvertent photocoagulation with Smart532, especially close to the fovea or the optic nerve head, can cause permanent visual loss. Major retinal vessels should be avoided. For a complete list of contraindications and risks, refer to the operator manuals.

PB-00026290 Rev B